Sanofi (SNYNF) Short-term Investments (2009 - 2021)

Sanofi has reported Short-term Investments for 13 years, with the latest figure at $12.5 million in Q4 2021.

• Quarterly Short-term Investments fell 93.18% year-over-year to $12.5 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $12.5 million (down 93.18% YoY) and the FY2021 annual result came in at $12.9 million, down 92.64% from the prior year.
• Short-term Investments slipped to $12.5 million in Q4 2021 per SNYNF's latest filing, from $182.9 million in the prior quarter.
• Over five years, Short-term Investments peaked at $227.1 million in Q4 2018 and troughed at $12.5 million in Q4 2021.
• A 5-year average of $132.0 million and a median of $147.0 million in 2019 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2017 and 2021: Short-term Investments jumped 170.86% in 2017, then slumped 93.18% in 2021.
• Over 5 years, Short-term Investments stood at $90.7 million in 2017, then soared by 150.53% to $227.1 million in 2018, then plunged by 35.28% to $147.0 million in 2019, then increased by 24.42% to $182.9 million in 2020, then slumped by 93.18% to $12.5 million in 2021.
• According to Business Quant data, Short-term Investments over the past three periods registered $12.5 million, $182.9 million, and $147.0 million for Q4 2021, Q4 2020, and Q4 2019 respectively.